Market Tracker

02/05 5:16pm ET

NewLink Genetics Corp (NASDAQ:NLNK)

23.23
Delayed Data
As of Feb 05
 -2.22 / -8.72%
Today’s Change
22.89
Today|||52-Week Range
58.73
-36.16%
Year-to-Date

Today’s Trading

Previous close25.45
Today’s open25.14
Day’s range22.89 - 26.49
Volume526,182
Average volume (3 months)533,636
Market cap$668.7M
Dividend yield--
Data as of 4:00pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-146.57%
Earnings growth (next 5 years)--
Revenue growth (last year)+15,690.67%
P/E ratio6.8
Price/Sales7.15
Price/Book3.03

Competitors

 Today’s
change
Today’s
% change
ZIOPZIOPHARM Oncology In...-0.25-4.67%
TBPHTheravance Biopharma...-0.01-0.06%
RGENRepligen Corp-0.83-3.80%
HRTXHeron Therapeutics I...-1.51-7.26%
Data as of 4:00pm ET, 02/05/2016

Financials

Next reporting dateFebruary 25, 2016
EPS forecast (this quarter)-$0.92
Annual revenue (last year)$172.6M
Annual profit (last year)$102.9M
Net profit margin59.60%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive &
Scientific Officer
Charles J. Link
President, Director &
Chief Medical Officer
Nicholas N. Vahanian
Corporate headquarters
Ames, Iowa

Forecasts